Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis

This study compared 5-year mortality, composite hepatic decompensation risk, and hepatocellular carcinoma ...

Source: BMC Gastroenterology - December 19, 2023 Category: Gastroenterology Authors: Daniel J Huynh, Benjamin D Renelus and Daniel S Jamorabo Tags: Research Source Type: research